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ABSTRACT

UTILIZATION OF EMULSION CHEMISTRIES FOR DELIVERY AND ANTIVIRAL
APPLICATION OF CARVACROL
FEBUARY 2020
HAO-YUAN HSU, B.S., ASIA UNIVERSITY, TAIWAN
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST
Directed by: Professor Matthew D. Moore
Human norovirus (HuNoVs) are the most common enteric pathogen around the world that
cause ~50% of foodborne illness of disease outbreaks annually. HuNoVs are the member of
the Caliciviridae family, which consist of small (38 nm), unenveloped, single stranded RNA
(ssRNA) viruses. Norovirus are divided into 5 genogroup (GI, GII, GIII, GIV, GV, GVI and
GVII). The GI, GII, and GIV cause human illness, in addition, GII.4 genotype cause the
most human disease. Due to HuNoVs are difficult cultured in vitro, the cultivable HuNoVs
surrogates have been widely studied. Recently, some studies have been conducted with
HuNoVs surrogates, for example bacteriophage MS2. MS2 is conservative surrogate for
nonenveloped viruses which there is a close relationship to the behavior of HuNoVs, thus
we can examine the infection control measures for HuNoVs. Despite plenty of treatment
method been done on testing antiviral effect on bacteriophage MS2, for example UV
inactivation, steam ultrasound and antimicrobial etc., plant-based nanoemulsion treatment
has yet to be explored. Carvacrol is a major component of oregano essential oil and is
responsible for their antimicrobial activity on the growth of various microorganism. In this
study, carvacrol nanoemulsions were formed by using the spontaneous emulsification for
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testing the nanoemulsion stability (14 days shelf life study on its droplet size and particle
charge) and antimicrobial activity.

In carvacrol nanoemulsion 14 days shelf life test, the droplet size and particle charge stay
stable at three different treatment environments (4°C, 20°C and 37°C). The results proved
that nanoemulsion (was formed with surfactant agents and medium-chain triglycerides) is
stable system that gives consistent droplet size and charge. Although, the low antimicrobial
activity was investigated at carvacrol nanoemulsion, the strong antimicrobial effects have
been found when carvacrol or carvacrol combined with ionic surfactant of treatment on MS2
and Escherichia coli. Taken together, in the wake of growing consumer demand for different
“natural” products in a number of industries, our study broadly informs the development and
study of functionalized carvacrol active compound that can not only provide beneficial
health for human but can also examine antimicrobial efficacy of control measures for public
health.
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CHAPTER 1
REVIEW: DEVELOPMENTS IN INACTIVATION OF INFECTIOUS HUMAN
NOROVIRUSES
1.1. Introduction
HuNoVs are the most common cause of epidemic and sporadic acute gastroenteritis around
the world which are belong to the member of the Caliciviridae family. Noroviruses (NoVs)
consist of small, 38 nm, nonenveloped single stranded RNA (ssRNA) viruses they are
divided into 5 genogroups (GI, GII, GIII, GIV, GV, GVI and GVII); of which genogroups
I, II and IV cause human illness. The genotypes are further divided from genogroup, and
GII.4 causing the most HuNoVs disease (Moore et al., 2015). HuNoVs have a low infectious
dose, as few as 18 viral particles, and it can be spread through fecal-oral-transmission,
deposition on surfaces, and through airborne droplets of vomitus. Furthermore, HuNoVs
can be easily spread through consumption of food, water and environmentally after
deposition on surfaces. Therefore, identification and use of effective HuNoVs inactivation
agents are crucially researched.

Although, in vitro cultivation techniques for HuNoVs have been reported (Ettayebi et al.,
2016; Jones et al., 2014), these still difficult for utilizing on the study of HuNoVs
inactivation. Therefore, reverse transcriptase quantitative polymerase chain reaction (RTqPCR) is commonly used to quantify HuNoVs inactivation. However, viral reduction of
RT-qPCR signal does not completely correspond to viral infectivity. Although, some
techniques (porcine gastric mucin (PGM) binding assay) have been developed for use in
conjunction with RT-qPCR (Manuel et al., 2018), the technique still cannot completely
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present the entire RNA sequence for RT-qPCR. This is due to the fact that infectious or
damaged protein may still attach with RT-qPCR when detect the antiviral effect. In addition
to RT-qPCR, HuNoVs inactivation is also considered by using the close relationship of
cultivable surrogate viruses; however, these surrogates have potential limitations in their
translation to HuNoVs inactivation (Richards, 2012). Using these methods and treatments,
numerous antimicrobial agents have been investigated; however, the identification of
effective agents that are not consider for food grade supply. Additionally, numerous
advances and investigation of HuNoVs inactivation agents have been reported in recent
years. The purpose of this review is to present recent studies on HuNoVs inactivation that
specifically by utilizing HuNoVs.
1.2. Human Norovirus Inactivation on Hands, Finger Pads or With Hand Sanitizer
The efficiency of handwashing with soap and water containing sterillium propan-1-ol 30%
and mecetroniumetil sulfate sterillium, Viruguard hand disinfectants and Unicura hand soap
were tested against NoVs GI.4 and GII.4 using finger pad tests (Tuladhar et al., 2015). The
finger pads were contaminated with virus and dried before being applied to the treatments.
Washing with soap and water removed genomic copies of noroviruses GI.4 (>6 log10), and
GII.4 (4 log10) completely from all finger pads. Treating hands with propanol-based hand
disinfectant showed low or no reduction to complete reduction with mean genomic copy
reduction of NoVs GI.4 (>2.6 log10) and GII.4 (>3.3 log10) showed in Table 1.

In a recent study, two alcohol-based hand washes, quaternary ammonium compounds and
chlorine dioxide were all ineffective at promoting virolysis of human norovirus (Nowak et
al., 2011). However, it was found that NoVs GII.4 were sensitive (99.92% RNA digested)
to a combination of heat and alkali condition (0.1M NaOH at 50◦C) (Table 1). The authors
examined the persistence of the NoV GII.4 by RT-qPCR for the amplification, for detecting
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on inactivation effect.

Another study presented in 2010 has tested the effectiveness of sodium hypochlorite and
ethanol (Liu et al., 2010) at different concentrations. The antibacterial hand sanitizer were
observed for the inactivation of norovirus on finger pads. It was found that sodium
hypochlorite has strong inactivation between 160 ppm and 1600 ppm after an exposure of
30s, a 5 log10 reduction was observed at sodium hypochlorite concentrations of 160 and
1,600 ppm on GI.1 (Table 1). At ethanol test, 3, 17, 31, 47, 62, and 95% concentrations were
low antiviral efficacy (0.5 log10 reduction). Antibacterial liquid soap treatment gave a
reduction of 0.67 to 1.20 log10 reduction and a water rinse only gave 0.58 to 1.58 log10
reduction. The alcohol-based hand sanitizer was low inactivation, reducing the norovirus
genomic copies less than water alone, with only a 0.14 to 0.34 log10 reduction. The treatments
in this study suggest that ethanol should not be used as an inactivation method.

VIRUS

INACTIVA

RANGE OF

QUANTIFICA

RANGE

REFERE
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TION

CONCENTRA

TION

OF

NCE

AGENT

TIONS OR

METHOD

REDUCTI

TREATMENT

ONS

TIME
GI.4,

Washing with

GII.4

GI.4:>6

(Tuladhar

soap and

log10, GII.4:

et al.,

water

4 log10

2015)

PCR units

GI.4: >2.6

(Tuladhar

(PCRU)/mL

log10

et al.,

GII.4: 3.3

2015)

GI.4

Propanol-

GII.4

based hand

30 s

Real-time PCR

30min

disinfectant

log10

3

GII.4

NaOH

0.1M at 50◦C

RT-qPCR

99.92%

(Nowak et

RNA

al., 2011)

digested
GI.1

GI.1

GI.1

Sodium

160 and

Suspension

hypochlorite

1600ppm for 30 s

assay

Ethanol

All concentration

Suspension

for 30s

assay

30s

RT-PCR

Antibacterial

Water rinse

30s

(Liu et al.,
2010)

0.5 log10

(Liu et al.,
2010)

0.67 to 1.20

(Liu et al.,

log10

2010)

American

0.58 to 1.58

(Liu et al.,

Society for

log10

2010)

0.14 to 0.34

(Liu et al.,

log10

2010)

liquid soap
GI.1

5 log10

Testing and
Materials
(ASTM)
GI.1

Alcohol-

Containing 62%

based

ethyl alcohol for

handwash

30s

ASTM

Table 1. Inactivation of HuNoVs on hands, finger pads or with hand sanitizer

1.3. Human Norovirus Inactivation on Hard Surfaces
For a study conducted in 2017, the authors applied 7.5% hydrogen peroxide and a 0.2%
chlorine dioxide-surfactant-based product using a fogging delivery system against NoVs
GI.6 and GII.4 (Montazeri et al., 2017). At 12.4 ml/m3 hydrogen peroxide, disinfectant
achieved a 2.5 ± 0.1 and 2.7 ± 0.3 log10 reduction in NoV GI.6 and GII.4 genome copies
within 5 min (Table 2). At the same disinfectant formulation concentration, 12.4 ml/m3
chlorine dioxide-surfactant-based product resulted in 1.7 ± 0.2 and 0.6 log10 reduction in
GI.6 and GII.4 within 10 min. However, increasing the disinfectant formulation
concentration to 15.9 ml/m3 negatively impacted its efficacy.
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The efficiency (Table 2) of neutral electrolyzed water (NEW) was observed for the
inactivation of GII.4 in suspension on stainless steel surfaces with and without an additional
soil load (Norovirus et al., 2017). The degradation norovirus VP1 major capsid protein at
250 ppm around 5min, and increased virus particle aggregation at 150 ppm after 30min.
Only the 250 ppm NEW concentration, without soil load, produced greater than a 5.4 log10
reduction in NoVs genome copy number. The contact time on surfaces to 5, 10 and 15 min
reduced HuNoVs genomic copies by 0.5, 1.6 and 2.4 log10. Moreover, NEW at 250 ppm
free available chlorine produced a 4.8 and 0.4 log10 reduction in norovirus genome copy
number after 1 min in suspension and on stainless steel.

A blend of silver ions and citric acid (SDC) had an effect on HuNoVs GI.6 and GII.4
(Manuel et al., 2017). The suspension assays showed a 4 log10 reduction in RNA copy
number within 5 min for both GI.6 and GII.4, along with a 2–3 log10 reduction in 30min
(Table 2). The results showed no further additional log10 reduction when extend over than
5min. When incorporating a simulated soil load into the sample matrix significantly reduced
formulation efficacy, ~2.5 log10 was achieved on both GI.6 and GII.4.

Fecal suspensions for a HuNoVs GII.4 or virus-like particles (VLPs) were exposed to
copper alloys or stainless steel for 0, 60, 120, and 240min in a study conducted in 2015
(Manuel et al., 2015). When using RT-qPCR assays on stainless-steel, there was a 1.1 log10
reduction in RNA copy number after a time of 240min (Table 2). When exposed for 60 min,
a 2–3 log10 reduction in RNA copy number was observed for surfaces containing 70%
copper. The research also showed further evidence that although there was damage to the
NoVs GII.4 capsid, HuNoVs remained stable on stainless steel surfaces for up to 240 min.
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For a study in 2014, the authors applied different concentration of ethanol solutions, 70%
and 90%, to test the reductions of NoVs GI.1, GI.5, GI.5 semi purified (SP) preparations,
GII.13, and GII.13 SP preparations RNA levels after 1 min of exposure (Cromeans et al.,
2014). The GI.1 RNA was reduced by as much as 1.1 log10 units on 90% of ethanol
concentration, however, 70% was reduced by less than 1 log10 unit. The GI.5 SP RNA level
was reduced by as much as 3.5 log10 units on both 70% and 90 % of ethanol concentration
(Table 2). And GI.5 reach 2.0 log10 unit of reduction on 90% of ethanol concentration,
whereas the GII.13 and GII.13 SP RNA levels were reduced <1 log10 unit. In the same
article, the viruses were dried on stainless steel with fifty microliters of a chlorine solution
at concentrations of 200 ppm or 1,000 ppm. Each was added to the virus for 5min. The GI.5
SP RNA level was reduced by <1 log10 unit after treatment with both 200 and 1,000 ppm
chlorine. The GII.13 SP RNA level was reduced by <0.5 log10 unit at concentrations of 200
ppm or 1,000 ppm.

The qualities of HuNoVs attached to stainless steel disks was also observed in an article
published in 2010. (Girard et al., 2010). The paper wanted to observe a technique for
disinfecting NoVs using household disinfectants. The attachment of HuNoVs and murine
norovirus (MNV) to stainless steel disks was tested against a range of pH and relative
humidity (RH). The maximum attachment of 103 PFU was obtained after a contact time of
10 min. Interestingly, extending the contact time to 60 or 120min did not increase viral. A
decrease in titer was more significant at low RH. When using household items for chemical
treatments, sodium hypochlorite showed inactivation exceeding 3 log10 reduction for
HuNoVs after a contact time of 10min (Table 2); however, only a 2 log10 reduction was
obtained after 5 min. The study suggests that MNV was more sensitive than HuNoVs to
chemical disinfectants. In the evaluation of disinfection efficacy, only sodium hypochlorite
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was effective against NoVs.
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Table 2. Inactivation of HuNoVs on hard surface

1.4. Human Norovirus Inactivation in Solution
In 2017, peracetic acid (PAA) and monochloramine in both wastewater (WW) and
phosphate buffer (PB) were tested for their ability to inactive HuNoVs GI and GII (Dunkin
et al., 2017). A 3.3 log10 reductions of GI was found when treated with 15 mg/l at a dose
of monochloramine after 120 min with enzymatic pretreatment (EPT) (Table 3). At a high
dose of 10 mg/l PAA predicted reductions of GI were 3.3 with EPT. In PB,
monochloramine and PAA exhibited similar effectiveness against GI and GII, both
disinfectants were able to achieve approximately 3 log10 reduction. In WW,
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monochloramine and PAA were more effective in treating GI. Monochloramine was able
to achieve ~ 2 log10 reduction of GI, while PAA has only achieved less than 1 log10
reduction. However, GII in WW as for both disinfectants were unable to achieve even 0.5
log10 reduction.

One in 2016 looked at ethanol, sodium hypochlorite, hydrogen peroxide, quaternary
ammonium compounds, and iodine using an anti NoV GII.4 monoclonal antibody
conjugated immunomagnetic separation (IMS) combined with qRT-PCR (Ha et al., 2016).
Ethanol was diluted between 10%-70% and had no disinfection effect against GII.4 as
shown by the less than 1 log10 reduction (Table 3). Sodium hypochlorite at 200, 500, and
1000 ppm resulted in mean log10 reductions of 1.55, 1.85, and 2.45 (Table 3); however,
50 and 100 ppm sodium hypochlorite shown by the log10 reductions of less than 1. Alkyl
dimethyl benzyl ammonium chloride (40%), containing quaternary ammonium of
treatments at 200, 1,000, and 2000 ppm achieved log10 reductions of 0.06 ± 0.12, 0.19 ±
0.13, and 0.58 ± 0.33 In this study, 200 and 1000 ppm quaternary ammonium compounds
had almost no effect, and 2000 ppm demonstrated a mean log10 reduction of less than 1
after 10 min of contact. Iodine (99.99% trace metal basis) was diluted with deionized
sterile water to 25, 100, 250, and 500 ppm. A 0.30 ± 0.05, 0.41 ± 0.06, 0.57 ± 0.14, and
0.71 ± 0.13 log10 reduced of NoV GII.4 was found.

One study (Koromyslova et al., 2015) found that NoVs that authors treated VLPs with
different concentrations of citrate buffer. Between 0.49 and 7.85 mM of citrate buffer, the
VLPs appeared no effect compared with untreated VLPs. However, at 15.63 mM, a small
number of the VLPs had slightly altered morphology, i.e., the outer spikes of the VLPs
were surrounded by a new ring-like structure. Where at 62.50 mM of citrate buffer the
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majority of VLPs showed the ring-like structure. The diameters of the VLPs were
manually measured at 0, 0.95, 7.81, 62.50, and 125 mM of citrate buffer shown in Table
3. At 0, 1, and 7.81 mM of citrate buffer, the diameter of the VLPs were 42 to 44 nm,
while at 62.50 and 125 mM of citrate buffer, the diameter of the VLPs were 46 to 49 nm.

In another study, it was found that antiviral activity on NoVs were generally < 0.5 log10
reduction for both GII.2 and GII.4 when using 50, 70, and 90% ethanol solutions tested at
(Grace et al., 2013). The disinfection efficacy for sodium hypochlorite, authors tested at
concentrations of 5, 75, 250, 500, and 1,000 ppm. The results showed no significant
inactivation at < 1,000 ppm on GII.2 strain. However, for the GII.4, efficacy was only
observed at the highest concentration tested, 1,000 ppm, there was a strong antiviral (4.5
log10) reduction in viral genome copy number (Table 3). The quaternary ammonium
compound blend were ineffective at inactivating both strains, with < 0.5 log reductions at
all concentrations on GII.2 and GII.4.

Different concentrations of 50%, 70%, 90%, of ethanol and isopropanol were tested for
inactivation in an article published by Park in 2016 (Park et al., 2016). NoVs positive stool
specimens (14 GI and 16 GII) and three stool samples of GI.1 (from human volunteers)
were suspended in ethanol and isopropanol. The result showed that exposure to 70% and
90% ethanol reduced viral RNA titers of 9 and 13 of the 14 GI strains by > 1.8 log 10
reduction shown in Table 3. The titers of 4 (3 GI.6 and 1 GI.7) of the GI strains were >
1.8 log10 reduction after exposure to 90% isopropanol, whereas no RNA reduction was
observed for 50% ethanol, or for 50% and 70% isopropanol. Exposure to 90% alcohols
achieved 0.9 log10 reduction of all 9 GII.4 strains. Overall, exposure to 70% and 90%
ethanol and 90% isopropanol resulted with an average of 1.2 ± 1.1, 1.4 ± 0.9, and 1.0 ±
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0.8 log10 reduction on RAN copies. After exposure to 50% and 70% ethanol, RNA titers
of GII.4 Den Haag and GII.4 Sydney viruses were showed >1.9 log10 reduction whereas
the titers for GII.4 New Orleans viruses were reduced by less than 0.5 log 10 reduction.
After exposure to 50% isopropanol, RNA titers of both GII.4 Den Haag viruses and 3 of
the 4 GII.4 Sydney viruses were achieved > 1.0 log10 reduction, while RNA titers of GII.4
New Orleans were reduced by 0.5 log10 RNA copies/ml.

It also has been stated that sodium hypochlorite, sodium hydroxide, sodium, ethanol,
carbonate, potassium carbonate, potassium hydroxide and hydroxide can in active NoVs
VLPs (Sato et al., 2016). The treatment on VLPs shown no change after 30s and 60s
exposures to 200 ppm sodium hypochlorite, but were slightly deformed after exposure for
180s. VLPs were also slightly changed morphologically within 30s of exposure to 50%
ethanol, but deformation after 60s with 60% ethanol. However, VLPs did not change
morphologically after 180s of exposure to 12.5 mM carbonate but were slightly deformed
after exposure to 25 mM for 10s. Deformation of VLPs was more marked after exposure
to 25mM for 60s. Deformation and aggregation of VLPs were observed after exposure to
sodium hydroxide and potassium hydroxide under specific conditions (Table 3). There
were no significant differences between the morphology of particles treated with sodium
and that of those treated with potassium hydroxide. VLPs were slightly deformed
morphologically within 180s of exposure to 25mM hydroxide and within 10s of exposure
to 50mM hydroxide.

Another study looked at the interactions of NoVs GII.4 with available chlorine (Illarruellopez, 2012). The results support the idea that the matrix effects have a significant effect
on virus survival. GII.4 virolysis was measured using RNase pretreatment and RT-QPCR.
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The 610ppm available chlorine at 10-13% concentration required to reduce GII.4 >4 log10
reduction in infectivity (Table 3).

Another study has observed sodium hypochlorite (Liu et al., 2015) at a concentration of
1600 ppm, produced complete inactivation of GI.1with an average of 4.84 log10 reduction
and also completely inactivated GII.4 with an average 3.74 log10 reduction in 2min contact
time. In contrast, 70% ethanol exhibited low antiviral activity, 0.81 and 0.14 log10
reduction for GI.1 and GII.4. Ammonium chloride exhibited no effect against either
GI.1or GII.4. The disinfectant Oxivir-TB with 0.5% hydrogen peroxide exhibited 1.11
and 0.94 log10 reductions against GI.1and GII.4. Lysol with lactic acid, produced 2.29
log10 reduction in GI.1 and an average log10 reduction in GII.4 of 0.21. Exposure to the
prototype disinfectant resulted in the greatest reductions of GI.1 (3.19 log10) and o GII.4
(1.38 log10) (Table 3).
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Table 3. Inactivation of HuNoVs in solution

1.5. High Pressure Inactivation on Human Norovirus
High pressure processing (HPP) inactivation is commercial used to process
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various kinds of foods mainly to increase their shelf life and enhance food safety
by inactivating pathogenic bacteria. It is commercially used as a processing aid;
for example, it has been used to facilitate oyster shucking. Commercially HPPtreated foods include those that have been involved in HuNoVs outbreaks, such
as oysters, salsa, and guacamole (Li et al., 2015).

In a study conducted in 2012, the effectiveness of HPP is observed for its ability
in disrupting the capsid of VLPs (Lou et al., 2012). Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was used, and the results
showed that the integrity of the capsid structure was not disrupted when HuNoV
VLPs were treated at 500 MPa for up to 30min. After pressurization for more
than 45 min, the number of 38-nm particles observed was notably reduced shown
in Table 4, while the 23-nm particles remained unaffected. The pressure was
increased to 600 MPa at 4°C for 5 to 60 min, the results were essentially similar
to those at 500 MPa. As the holding time increased to 60 min, the 38-nm VLPs
disappeared, whereas the 23-nm VLPs were still intact. The pressure level was
increased to 700 MPa, at 45 min, the 38-nm VLPs were undetectable (Table 4),
but a considerable number of 23-nm particles were still present. At 800 MPa, the
number of 38-nm VLPs was notably reduced after 15 min, and the 38-nm
particles were undetectable after a 30-min treatment. The number of 23-nm
particles also dramatically decreased after treatment at 800 MPa for 45 min. At
900 MPa, after a 1-min treatment, the number of 38-nm VLPs was significantly
reduced, and after 2 min, no intact 38-nm VLPs were detected and the number of
23-nm VLPs was dramatically reduced
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In 2011, it was also observed applying a high hydrostatic pressure (HHP)
treatment can be used to inactive HuNoVs in HPP (Sanchez et al., 2011).
Different time and pressure conditions were used on each sample, being 200, 300,
350, 400, 450, and 500 MPa for 15min at initial temperatures of 25°C and 45°C.
All tested treatments reduced the numbers of HuNoV by < 0.5 log10 reduction as
determined by RT-qPCR (Table 4); in other words, NoV was detected by RTqPCR even after treatments at 500 MPa for 15 min. Similarly, the effect of HPP
on NoVs in CaCl2 resulted in inactivation no higher than 0.5 log10 reduction
independently of treatment temperature.

In a more recent study from 2017, high hydrostatic pressure (HHP) was used on
GII.4 and GI.1 when found on green onions and salsa (Sido et al., 2017). HHP
inactivation studies were conducted at 100–600 MPa for 2 min at an initial
temperature of 1°C to determine optimum HHP processing conditions. It was
desired to achieve a ≥3 log reduction of the strains. To achieve >3 log10 reduction
of GI.1, HHP treatment should be conducted at 600MPa and 500MPa for green
onions and salsa respectively. To achieve >3 log reduction of GII.4, HHP
treatment should be conducted at 500 MPa and 300MPa for green onions and
salsa respectively. For green onions, HHP treatment could reduce GI.1 by >3.0
log10 at 600 MPa while >3.87 log reduction was achieved for GII.4 under the
same condition (Table 4). The HHP treatment of 300 MPa reduced HuNoV GII.4
by 3.31 log10 reduction in salsa and 2.57 log10 reduction on green onions. Similar
results were also found with salsa which showed 1.39 log10 reduction of HuNoV
GI.1 and 3.52 log10 reduction of HuNoV GII.4 at 400 MPa. Food matrices also
influenced HHP inactivation of GI.1 and GII.4, HuNoV showing higher
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sensitivity to HHP treatment in salsa than on green onions.

Another group compared the results of HHP inactivation of a GI.1 and GII.4
strain using different PGM-MB/PCR (Li et al., 2015). HuNoV GII.4 and GI.1
were pressurized at 150 to 550, 50 to 400, 250 to 575, and 100 to 450 MPa by
using an Avure PT-1 pressure unit. There was no virus inactivation at low
pressure levels (50 to 200 MPa), and inactivation was found the pressure was
increased above 550MPa. Results showed the HHP inactivation of GI.1 which
showed the maximum of ~3 log reduction at 21°C natural PH under 550MPa and
21°C PH 4 under 550MPa. GII.4 had a maximum reduction of ~3.5 log10 units at
both 4°C and 21°C natural PH under 250MPa (Table 4). However, increasing the
pressure did not result in greater reduction. Both the GI.1 and the GII.4 strains
were more sensitive to pressure at 4°C than at 21°C, along with neutral pH than
at pH 4. It can be consulted that the GI.1 strain was more resistant to pressure
than the GII.4 strain addressed Li in 2015.

In another study, it was found that HHP inactivation on HuNoV GI.1 and GII.4
strains under different pressure levels and temperatures were obtained using the
direct RT-qPCR, PGM/PCR and PMA/ PCR assays (Li et al., 2017). HuNoV
GI.1, and HuNoV GII.4 samples were HHP treated at 50–300, 250–550, and 100–
400 MPa, respectively. HHP treatments were conducted at initial sample
temperatures of 4 and 21 °C for 2 min using an Avure PT-1 pressure unit. Except
for the HHP treatment of HuNoV GI.1 at 21 °C, direct RT-qPCR showed a <1.0
log10 reduction at all pressure level. At 500MPa pressure levels at 21°C, the
PMA/PCR assay showed >2.5 log10 reduction of HuNoV GI.1 and ~1.7 log10
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reduction at PGM/ PCR assay shown in Table 4. At 400MPa pressure levels at
21°C, the PMA/PCR assay and PGM/ PCR assay both showed >2.5 log10
reduction of HuNoV GI.1. For HuNoV GII.4, a maximum inactivation (~3.5 log10
reduction) was observed for both the PGM/PCR and PMA/PCR assays. The
direct RT-qPCR showed much lower inactivation effect of HuNoV comparing to
the other two assays. It could be logically concluded that the PGM/PCR and
PMA/PCR assays were both better than the direct RT-qPCR assay.
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Table 4. High pressure inactivation of HuNoVs

1.6. Other Human Norovirus Inactivation Studies
Another study in 2017 (Li et al., 2017) compared the heat and HHP using HuNoV GI.1
strain and a GII.4 strains under different temperatures. The virus was evaluated using those
different molecular assays by using the direct RT-qPCR, PGM/PCR, and PMA/PCR assays.
For GI.1, the direct RT-qPCR assay showed no inactivation for all heat treatments at 60 to
90°C. The PGM/PCR assay and PMA/PCR assay showed different inactivation result. For
example, for a 2min heat treatment at 90°C, PGM/PCR assay showed a 2.2 log 10 reduction
(Table 5) while PMA/PCR assay showed no inactivation (0-1.2 log10 reduction) from 60 to
80°C. The PGM/PCR assay showed a when increase of heat inactivation effect of GI.1 from
60 to 70°C followed by increase from 70 to 90°C (1.2 to 2.1 log10 reduction). As for HuNoV
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GII.4, all three assays showed similar inactivation results, almost no inactivation of GII.4
from 60 to 80°C.

One study applied sodium metasilicate and sodium hypochlorite to fresh vegetables (Ha, et
al., 2017). The research evaluated the efficacy of a range concentrations of 50-1000 ppm
NaOCl, for reducing the amounts of HuNoV GII.4 on lettuce, celery, and white cabbage.
The reductions of GII.4 were 3.17, 3.06, and 3.27 log10 reduction for lettuce, celery, and
cabbage, respectively, at 1000 ppm NaOCl, while a reduction of similar to 3 log10 reduction
was obtained when the samples were treated with 100ppm NaOCl combined with 0.4%
SMS pentahydrate (Table 5). Taken together, these results demonstrated that combined
treatment with NaOCl and SMS pentahydrate was an efficient antimicrobial to reduce the
concentration of NaOCl for HuNoV GII.4 contamination in fresh vegetables.

The stability and attachment to lettuce has also been observed. (Wang et al., 2012). The
results have showed that after incubation for 30min at 56°C, HuNoVs has low effect but it
changed significantly after 2 hours treatment, with a < 1.0 log10 reduction in both
GII.12/HS200 and GII.4/HS194. In the ethanol treatment, strains were treated with two
commonly used concentrations of ethanol, 60% and 70%, at room temperature for 5min,
the results showed the RNA reduce with 1.51±0.15 and 1.37±0.32 log10 unites compared to
water control. The resistance to chlorine treatment of HuNoVs showed that both virus’ RNA
became undetectable after sodium hypochlorite concentrations were increased to 200 mg/l.

In 2013, PGM-MB were used to inactive HuNoVs (Kingsley et al., 2014). The ability of
HuNoV to bind to PGM-MBs was assessed after 1min treatments with effective
concentrations of 33, 173, and 189 ppm of chlorine, respectively. As compared to the
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untreated control, log10 reductions were 1.48 ± 0.42, 3.65 ± 0.41, and 4.14 ± 0.54,
respectively. Initially, concentrations of 240 ppm chlorine dioxide were evaluated for 1 min.
However limited inactivation (~0.33 log10) was observed. Consequently, 240 ppm ClO2
treatments were extended to up to 60 min. Results indicated that 10, 30, and 60 min
treatments with 240 ppm ClO2 gave 0.8 ± 0.24, 1.5 ± 0.42 and 2.8 ± 1.27 log10 reduction
(Table 5), respectively. For 4% concentration of H2O2, exposing HuNoV for 1 min, a low
log10 reduction (~0.1 log10) was observed. The effect of trisodium phosphate (TSP) was also
evaluated by mixing 5% TSP with HuNoV for 5, 15, and 30min treatments followed by
PGM-MB and qRT-PCR assay. Results indicated that exposure to 5% TSP for 5min was
reduced binding by 1.6 ± 0.58. log10. When increased the contact time to 15 and 30min, did
not result in substantially greater reductions.

In 2010, HuNoV was inoculated into chlorination and bench-scale free chlorine that
performed for 0.1 and 0.5 mg l

-1

concentrations, (Kitajima et al., 2010). At free chlorine

concentrations 0.5 mg l -1, a reduction in HuNoV from 1.10 to 3.64 log10 after contact time
(5 to 30 min) using the direct RT-qPCR while at 0.1mg l -1 achieved less than 0.1 log10
reduction after 30 min contact time (Table 5). Viral RNA titer was almost constant
regardless of the virus type. The results indicating similar persistence against free chlorine
disinfection. Recent studies also demonstrated that MNV was more sensitive to free chlorine
than other enteric viruses, and that HuNoV is not highly resistant to free chlorine
disinfection.
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GI.1

4% H2O2

1min

PGM-MB

~0.1 log10

qRT-PCR
HuNoV
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(Kingsley
et al.,2014)
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min
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log10

Table 5 Other HuNoVs inactivation studies

1.7. Conclusion
HuNoV GI and GII type of cause outbreaks among the population with majority
coming from GII.4. It is important to improve and understand methods of
inactivate to prevent these outbreaks on food and otherwise. Although many
researches have tested in vitro and in vivo cultivation methods, many methods
still have limitation on HuNoVs viral reduction. As Inactivation of HuNoVs has
been seen on a multitude study, for example, inactivation in solution, surfaces,
high pressure and other inactivation; washing with soap shown the highest
inactivation (>6 log10 reduction) in the review. Sodium hypochlorite (hand
soap), NEW on hard surfaces also showed >4 log10 reduction on HuNoVs
genome copies. Additionally, when inactivation in solution, 13% chlorine and
1000 ppm of 90% ethanol were achieved >4 log10 reduction. However, some of
inactivation methods showed the limited viral inactivation. For example, 200-500
MPa pressure level after 15 min HHP treatment on HuNoV achieved <0.5 log10
reduction also a 0.5 log10 reduction of HuNoV GII.4 after exposure to 50%
isopropanol. HuNoVs are resistant to quantification of different solutions is
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important for identifying agents that may be of more practical value in an applied
setting. Furthermore, the limitation of inactivation showed different sensitivity to
HuNoV strains GI and GII should be conducted. In addition to HuNoV existing
features as a near-perfect foodborne pathogen, we need to find more efficient
method even in vitro and in vivo cultivation because HuNoVs are so difficult to
study.

25

CHAPTER 2
GENERATION OF POSITIVELY CHARGED CARVACROL
NANOEMULSIONS AND THEIR SHELF LIFE
2.1. Abstract
Due to the low solubility of carvacrol in water, carvacrol must be delivered as a
nanoemulsion. In this study, we applied a low energy method (spontaneous
emulsification) to generate nanoemulsions containing carvacrol, medium chain
triglyceride (MCT) and surfactant. The most optimal carvacrol nanoemulsion
contained 10% (v/v) organic phase (0.33 to 1.0% carvacrol, 4.67 to 4.0% MCT,
and 5.0% Tween 80, v/v) and 90% aqueous phase (RNase-DNase-Free water
with 0.02% CTAB), and was produced at room temperature by spontaneous
emulsification. In order to enhance delivery application, we applied the
Cethyltrimethylammonium bromide (CTAB) to make the nanoemulsion contain
a positive charge, thus increasing the delivery of the carvacrol nanoemulsion to
negatively charged biological molecules of interest. The droplet size was
decreased (from d ≈ 200 to d ≈ 95 nm) and the mean Zeta-potential stay stable
(mean value from 11.0 to 13.0 mV) when carvacrol concentration was increased
from 0.33 to 1.0% (and MCT was decreased from 4.67 to 4.0% v/v). For 14 days
shelf life study, 0.5% carvacrol nanoemulsions droplet sizes and Zeta-potential
were examined at three different temperatures reflecting different potential
applications (37°C, 20°C and 4°C). The mean droplet size and Zeta-potential
were stable at three different temperatures for the duration of the test. The results
of this study inform the design and utilization of spontaneously formed,
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positively charged carvacrol nanoemulsions and the extent of their stability in a
number of different applications.
2.2. Introduction
Nanoemulsions are emulsions with droplet size on the order of 1 to 100 nm. A
typical nanoemulsion contains oil, surfactant and water. In order to prepare a
stable and smaller droplet size (d ≈ 100nm) of nanoemulsion, the droplet size,
stability and solubility were found to be dependent on the composition of
carvacrol nanoemulsion (type of surfactant, concentration of oil phase, ratio of
carvacrol to carrier oil, etc.) as well as the type of food matrix where the
carvacrol nanoemulsion is applied (Chang et al., 2013; Donsì et al., 2012).

Compared to oil-in-water emulsion, much more work can be done to understand
the behavior and stability of spontaneously formed nanoemulsions containing a
number of natural bioactive compounds in the light of increasing consumer
demand for “natural” products. The growing demand for the use of natural
additives has produced a substantial increase in the number of studies based on
natural extracts such as carvacrol or its main compounds in the last decade.
Carvacrol are categorized as Generally Recognized as Safe (GRAS), and are
therefore potential alternatives to chemical additives (Sanchez et al.,2015;
Mason et al., 2006).

The food industries have paid attention to the natural alternatives to assure food
safety and quality. Oregano is a natural food additive which bioactive
components are beneficial as flavoring or seasoning agents in some of the most
accepted cuisines around the world. Additionally, oregano oil is attributed to
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antioxidant effect from their major components, carvacrol and thymol, and it is
the result of various possible mechanisms: free-radical scavenging activity,
transition-metal-chelating activity, and/or singlet-oxygen- quenching capacity
(Shan et al., 2005).

Carvacrol are considered to present no risk to the health of consumers and have
been registered by U.S. Food and Drug Administration and generally recognized
as safe components (Burt et al., 2004). Additionally, carvacrol and thymol are
the main antimicrobial and antioxidant monoterpene phenolic compounds that
constitute 78–85% of oregano (Govaris et al., 2010). Its components are
potential natural food antimicrobials, which can meet the increasing demands of
fresh and chemical-additive-free food products from more health-conscious
consumers and legal authorities (Smith-Palmer et al., 1998). Moreover, the antiinflammatory potential of essential oils containing carvacrol and itself have been
investigated in details in various models of inflammation (Hotta et al., 2010;
Lima et al., 2013). Furthermore, another group (Lima et al., 2013) also
demonstrated that carvacrol exerts presets anti-inflammatory activity on a typical
mice inflammation model.

Over the past decade or more, the research focus has been on preparing
nanoemulsions through various methods, broadly classified into two primary
categories: high-energy and low-energy methods. High-energy methods utilize
mechanical devices that are capable of disrupting and intermingling the oil and
aqueous phases into tiny oil droplets dispersed in water. Low-energy methods
mainly rely on the spontaneous formation of droplets at the interface between oil
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and water phases and depend strongly on the nature of any surface-active
molecules present, e.g., their solubility and molecular geometry (Chang et al.
2013). Low energy approaches may have advantages over high-energy
approaches for certain applications: they are often more effective at producing
desired droplets, they have lower equipment and energy required, and they are
simpler to implement (Chang et al., 2013).

By contrast, nanoemulsions do not form spontaneously; an external shear must
be applied to separate larger droplets into smaller droplet. In this study, we
examine the potential of using the spontaneous emulsification method (lowenergy method) for producing carvacrol nanoemulsions. In general, this method
involves pouring an organic phase (containing oil and surfactant) into an aqueous
phase, which leads to the spontaneous formation of desired droplets due to rapid
diffusion of the surfactant from the oil phase into the aqueous phase (Anton et
al., 2009). The movement of the hydrophilic surfactant from the oil phase to the
aqueous phase after mixing leads to the spontaneous formation of desired oil
droplets at the oil−water boundary. This method allows nanoemulsions to be
produced at room temperature using simple stirring rather than expensive
homogenization equipment (Chang et al., 2013).

Nanoemulsions are kinetically stable, but given sufficient time, will separate into
different phases. The different destabilization mechanisms of nanoemulsions are
primarily flocculation, coalescence, and Ostwald ripening. In flocculation,
droplets come closer to each other because of attractive interactions and move
as a single entity. In contrast, in coalescence, the droplets merge into each other
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to become a bigger droplet. Ostwald ripening occurs due to the difference in
chemical potential of solute within droplets of different sizes. The chemical
potential of the dispersed phase provides the driving force for mass transfer from
the smaller to the larger droplets. Thus, the smaller droplets become smaller and
the larger droplets grow (Gupta et al., 2016).

To make stable nanoemulsions, we can apply MCT to stabilize nanoemulsions
due to its highly nonpolar nature. In this study, MCT was beneficial not only for
the spontaneous formation of carvacrol nanoemulsions but also for ensuring their
shelf life stability test, to avoid Ostwald ripening and coalescence inhibitor
(Chang et al., 2013). The addition of nonpolar triglyceride oils (such as MCT)
may therefore have decreased the coalescence rate by decreasing the polarity and
increasing the interfacial tension. An alternative approach to enhancing the longterm stability of nanoemulsions would be to store the antimicrobial as an organic
phase containing carvacrol and carrier oil (MCT) and then add this organic phase
to an aqueous product when needed (Chang et al., 2013).

The addition of surfactant is critical for the creation of small sized droplets as it
decreases the interfacial tension i.e., the surface energy per unit area, between
the oil and water phases of the emulsion (Gupta et al., 2016). Carvacrol oil-inwater nanoemulsions can also stabilized by a nonionic surfactant (Tween 80).
Tween 80 dissolved in sterile deionized distilled water will be prepared to
determine the optimum interfacial composition to obtain small stable droplets
with high antimicrobial efficacy. The decrease in droplet size is because of the
accumulation of surfactant molecules at the interface which leads to increase in
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the interfacial area and decrease of the interfacial energy (Tadros et al., 2004).

Cethyltrimethylammonium bromide (CTAB) is a cationic surfactant that selfassembles as micelles, and other structures and phases depending on the
concentration and solvent characteristics. CTAB is appropriate for extraction of
biomolecules, since its cationic micelles are stable over a wide range of pH
(J¨onsson et al., 1998). Moreover, addition of a cationic surfactant to emulsions
can further enhance functionality and delivery to negatively charged target
molecules; for instance, it can enhance antimicrobial activity against bacteria by
better delivering antimicrobial to the negatively charged cell surface (Ziani et
al., 2011).
2.3. Materials and Methods
2.3.1. Carvacrol Nanoemulsion Materials
Purified carvacrol (>98%) was purchased from Sigma-Aldrich (St. Louis,
MO). Organic MCT oil was purchased from Nature's Way (Green Bay, WI).
Polyoxyethylene-80

(Tween

80)

and

Hexadecyltrimethylammonium

bromide (CTAB) were purchased from (Markham, ON). Sterile RNaseDNase-Free water and Phosphate-buffered saline (PBS) were purchased
from Thermo Fisher (Waltham, MA).
2.3.2. Nanoemulsion Preparation
Initially, to make carvacrol nanoemulsions, we first prepared aqueous phase
and lipid phase separately. Organic phases were prepared by mixing different
concentration (0.33, 0.5 or 1.0% v/v) of purified carvacrol, different
concentrations of MCT (4.67, 4.5 or 4% v/v) and 5.0% Tween 80 were added
to make a total organic phase of 10% (v/v) by using a stir bar for 15min at
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room temperature. The aqueous phase used to prepare the nanoemulsions
consisted of 0.02% of CTAB dispersed in 50ml of nuclease-free distilled
water at room temperature. The organic phase (10% v/v) was added then
mixed with aqueous phase (90% v/v) by using a manual dispenser
(Repeater® M4, Eppendorf, Hauppauge, NY). All components were mixed
for 30 min at 25°C.
2.3.3. Nanoemulsion Shelf Life Test
For the purposes of shelf life testing, a 0.5% carvacrol nanoemulsion was
evaluated, by generation of two nanoemulsions sealed in 100ml conical
flasks and then separately stored at 4°C, 20°C and 37°C for 14 days. We
separately tested each nanoemulsion sample (from 4°C, 20°C and 37°C
incubators and in each condition has two samples) at days 1, 3, 7 and 14
2.3.4. Droplet Size and Zeta-Potential Measurement
The particle size and zeta-potential of the nanoemulsions were determined
using (Zetasizer Nano ZS, Malvern Instruments, Worcestershire, UK).
Samples were diluted to an oil droplet concentration of 5.0% (v/v) using the
same buffer (nuclease-free distilled water) as the original sample to eliminate
multiple scattering effects. A measured refractive index value of 1.456 for
the 0.5% carvacrol mixed with 4.5% MCT was used. The refractive index of
the mixed oil phase was calculated by the mass fraction on a Refractometer
(Bausch & Lomb, Rochester, New York). The droplet size and Zeta-potential
were used to represent the mean particle diameter and surface potential of
the lipid droplets. After 60s of equilibrium, each sample was scanned three
times and the average was recorded. The Z-Average and Zeta-potential were
used to represent the mean particle diameter and surface potential of the lipid
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droplets.
2.3.5. Statistical Analysis
Nanoemulsion preparation experiments, Z-averages, and Zeta-potential
measurements were performed in triplicate on freshly prepared samples.
Nanoemulsion stability to shelf life test were tested from two samples at
different temperature environment by following manufacturer instructions at
60 seconds. The results were then reported as averages and standard
deviations of these measurements.
2.4. Results
2.4.1. Z-Average and Zeta-Potential of Oil Phase Composition on Nanoemulsion
Formation
The mean droplet diameter decreased from 220.8 nm to 112.3 and 95.5 nm
when the carvacrol concentration was increased from 0.33 to 0.5 and 1.0%
(Table 6) after combination with 4.67, 4.5 and 4.0% MCT and 5.0% Tween
80 and 90% aqueous phase, respectively. The mean Zeta-potential stayed
relatively stable, with mean values from (+)11.0-13.0 for the above
variations in conditions.

Carvacrol oil

MCT %

%

Tween 80

Aqueous phase

Mean droplet

Mean Zeta-

%

%

diameter (nm)

potential (mV)

0.33

4.7

5.0

90.0

220.8

11.3

0.5

4.5

5.0

90.0

112.3

13.0

1.0

4.0

5.0

90.0

95.5

11.0

Table 6. Effect of mean droplet diameter and mean Zeta-potential of carvacrol oil
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nanoemulsions fabricated combining with differing MCT concentration.
2.4.2. Storage Stability of 0.5% Carvacrol Nanoemulsions
We examined the influence of storage time on the stability of 0.5% carvacrol
nanoemulsions that were found to be stable to visible creaming over 14 days
at three different temperature (4°C, 20°C and 37°C). These systems consisted
of an oil phase (10% v/v) of 5% oil (0.5% carvacrol and 4.5% MCT), 5%
surfactant (Tween 80), and 90% aqueous phase (included nuclease-free
distilled water and 0.02%CTAB). Initially, these systems had different mean
diameters due to the influence of oil phase composition on the efficiency of
nanoemulsion formation. When 0.5% carvacrol nanoemulsion storage at 37°C
(body temperature for potential nutritional applications), the mean diameter
(Fig. 1) were relatively stable, ranging from 130.4-294.9 nm over 14 days. At
20°C (room temperature condition), mean diameter (Fig. 1) were also
relatively stable, ranging from 221.7-295.5 nm over 14 days. The mean
diameter (Fig. 1) were also relatively stable at 4°C, ranging from 215.7-277.8
nm over 14 days as similar results to 37°C and 20°C

The mean Zeta-potential (Fig. 2) were stable, the ranging from (+)12.1-17.9
mV over 14 days at 37°C. At 20°C and 4°C, the Zeta-Potential results were
similar to storage at 37°C, ranging from (+)14-18.7 mV over 14 days.
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Fig. 1. 0.5% nanoemulsion shelf-life study on Z-Average. Z-Average stays stable in mean
particle diameter of selected nanoemulsions during 14 days of storage at three different
temperature. Nanoemulsions were prepared using 5% oil (carvacrol + MCT of varying
ratios), 5% surfactant (Tween 80), and 90% aqueous phase (included deionized distilled
water and 0.02%CTAB) at a stirring speed of 700 rpm at ambient temperature (25 °C).
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Fig. 2. 0.5% nanoemulsion shelf-life study on Zeta-Potential. Zeta-Potential is stable with
mean particle diameter of selected nanoemulsions during 14 days of storage at three
different temperature. Nanoemulsions were prepared using 5% oil (carvacrol + MCT of
varying ratios), 5% surfactant (Tween80), and 90% aqueous phase (included deionized
distilled water and 0.02%CTAB) at a stirring speed of 700 rpm at ambient temperature
(25 °C)

2.5. Discussion
Initially, we examined the influence of organic and aqueous phase composition
on the initial size of the oil droplets and Zeta-potential in positively charged
nanoemulsions produced using spontaneous emulsification. Organic phase
composition was varied by combining different mass ratios of carvacro) and
MCT prior to emulsification. A present study (Flores et al., 2016) have applied
0.5% (v/v) carvacrol concentration with Tween 80 along with high-pressure
homogenization that generated emulsions with smaller droplet size, lower
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polydispersity index, and higher Zeta-potential. The presence of carvacrol and
Tween 80 in the emulsions and the use of high-pressure homogenization
decreased the emulsion contact angle because of the smaller droplet size and its
greater surface interaction, thus improving its wettability properties.

Therefore, the lower concentrations (0.33, 0.5 and 1.0%) of carvacrol
nanoemulsion were made in our study. The overall system composition reflected
what has previously been reported 5.0% oil phase (carvacrol + MCT), 5.0%
surfactant (Tween 80) and 90% aqueous phase (includes 0.02% CTAB). As the
carvacrol concentration in the oil phase increased (from 0.33 to 0.5 and 1.0%
v/v), the mean droplet diameter initially decreased (Table 6). To maintain a
droplet size within the range generally desired for nanoemulsions, we adjusted
the ratio between carvacrol and MCT (oil phase). For example, (Chang et al.,
2013) presented the systems containing 2.5% carvacrol and 7.5% MCT (25%
carvacrol and 75% MCT in oil phase) in the total nanoemulsion was created. In
this work, the composition of three different concentrations of nanoemulsion
were 0.33% (6.6% carvacrol and 93.4% MCT in oil phase), 0.5% (10% carvacrol
and 90% MCT in oil phase) and 1.0% (20% carvacrol and 80% MCT in oil phase)
formed mean droplet sizes of 220.8, 12.3 and 95.5 nm. This finding is in
agreement with previous studies of nanoemulsion formation using spontaneous
emulsification, as larger droplets can occur when too much MCT is added to the
oil phase because the efficiency of spontaneous emulsification decreases.
Consequently, an optimum MCT level is required (around 40%) to form stable
nanoemulsions (Ryu et al., 2018).
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In order to add delivery functionality, we applied 0.02% CTAB to give the
nanoemulsions a positively charged nanoemulsion which exhibited stable and
consistent Zeta-potential with three different concentrations (0.33, 0.5 and 1.0%
v/v) of carvacrol nanoemulsions. The mean Zeta-potential generally did not
fluctuate with different formulations, mean values from +11.3, +13.0, and 11.0
mV when the carvacrol concentration was increased from 0.33 to 0.5 and 1.0%
(Table 6), respectively. Since droplet charge may have an important impact on
nanoemulsion stability and antimicrobial efficacy, a recent study (Chang et al.,
2015) showed that a 0.1% cationic surfactant was added in thyme nanoemulsion
became positive charged (+18 mV), suggesting that at least some of the cationic
surfactant molecules adsorbed to the oil droplet surfaces.

Overall, our shelf life study suggested that the nanoemulsions will likely stay
stable in multiple application temperatures, ranging from refrigeration to body
temperature (Fig. 1). As nanoemulsion droplet size stayed stable (from d >100,
d < 300 nm) at three different temperatures (4°C, 20°C and 37°C) over 14 days.

At 4°C, the mean sizes ranged from 215.7-260.9 nm for days 1-14, then rapidly
decreased by day 21 to 130.4 nm. This result is largely in agreement with (Chen
et al., 2018) which presented their nanoemulsion with 10% carvacrol in oil phase
was stable (d ≈ 150 nm) at 4°C in 28 days shelf life test.

At 20°C, the mean sizes appeared very similar to 4oC, with sizes ranging from
222.7-264.1 nm for days 1-14. Another carvacrol nanoemulsion systems in study
(Chang et al., 2013), consisted of 10% carvacrol in oil phase (90% MCT in oil
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phase) that were found stable (d ≈ 5 nm) at ambient temperature (25°C) for 30
days shelf life test.

When 0.5% carvacrol nanoemulsion storage at 37°C in this study, the mean
diameter (Fig. 1) ranging from 130.4-294.9 nm over 14 days. Currently, there is
no study presented carvacrol nanoemulsion (at desired concentration of 10%
carvacrol in total oil phase) on 37°C for long term study. However, the study
(Dey et al., 2018) demonstrated that a different type of nanoemulsion 1.5% (w/v)
ω-3 PUFA rich fish oil plus 1% (wt /v) total surfactant (Tween 20 + Span 80)
performed nanoemulsion oil droplet size (d ≈ 175 nm) stable at 37°C for 4 weeks.

To our knowledge, no prior studies have reported the behavior and shelf life of
positively charged carvacrol nanoemulsions at different temperatures from
different applications. Nevertheless, the mean Zeta-Potential (Fig. 2) fluctuated
slightly but stayed stable (+12.1 to +18.7 mV) at three different temperatures
(4°C, 20°C and 37°C) on 14 days shelf life test in this study. It is due to the fact
in a more recent study (Kumar et al., 2018) exhibits the successful selection of
Tween 80 surfactant from given CTAB by characterization on the basis of their
surface active for stabilizing oil-in-water nanoemulsions

Overall, the 0.5% carvacrol nanoemulsion droplet size and Zeta-potential
remained relatively stable at three distinct temperatures (4°C, 20°C and 37°C)
for 14 days shelf life test. This is likely due to a higher amount (90% in total lipid
phase) of MCT enhancing the long-term stability (Chang et al., 2013). In order
to attempt to create smaller oil droplet size, we may increase the carvacrol
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concentration (30 to 40%) in total lipid phase while lower the MCT
concentration (70 to 60%) in total lipid phase. However, previous reports suggest
that this may give the nanoemulsion unstable when more than 25% of carvacrol
(in total oil phase) is used cause unstable nanoemulsions (Chang et al., 2013).
2.6. Conclusion
In sum, we optimized the formulation of and investigated the behavior of
positively charged, spontaneously formed carvacrol nanoemulsions. Further, we
evaluated the shelf life of these nanoemulsions at different potential application
temperatures (refrigeration, room, and body temperature). In the wake of
growing consumer demand for different “natural” products in a number of
industries, our study broadly informs the development and study of
functionalized carvacrol nanoemulsions that can be cheaply fabricated and are
stable in a range of application temperatures.

40

CHAPTER 3
CARVACROL NANOEMULSION ANTIMICROBIC EFFICACY ON
BACTERIOPHAGE MS2 AND ESCHERICHIA COLI
3.1. Abstract
The essential oils in plants contain complex mixtures with lipophilic and volatile secondary
metabolites. The antimicrobial active ingredient of essential oils can be the dominant
component, greater than 50% of the chemical composition in many cases. Additionally, the
natural plant antimicrobials have a higher acceptance at public, therefore the natural
essential oil active ingredients have been investigated for application on food to reduce
microorganism transmission. Carvacrol has previously been demonstrated to have a
moderate antiviral effect on noroviruses. Previous work has also demonstrated that
restructuring essential oils in positively charged nanoemulsions can enhance their
antimicrobial efficacy. The purpose of this work was to investigate if restructuring
carvacrol in positively charged nanoemulsions could enhance the antinoroviral efficacy of
carvacrol. Carvacrol nanoemulsions (0.5, 0.83% v/v) were dissolved in Dulbecco's
phosphate-buffered saline (DPBS), and the median particle size was 122.7nm and 123nm—
acceptable for nanoemulsions—and the median Zeta potential were -1.42 and -1.15mV at
0.5 and 0.83% carvacrol. Carvacrol nanoemulsions at 0.5 and 0.83% both displayed
negligible viral reduction. Therefore, we investigated efficacy with different aqueous phase
(nuclease-free distilled water) for dissolving carvacrol nanoemulsion. Due to carvacrol’s
low solubility in water, different concentrations of carvacrol nanoemulsion (0.5, 1.0% v/v)
were produced by a low energy method (Nano-emulsification) in nuclease-free distilled
water instead of DPBS. The median particle sizes were 112.3nm and 71.5nm, and Zeta-
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potential were +12.9 and 9.6mV. When applied against MS2, carvacrol nanoemulsion
(0.5%, 1.0% v/v carvacrol) with 60 min; 0.5% carvacrol nanoemulsion showed no
reduction on MS2. However, 1.0% carvacrol nanoemulsion showed a 0.73 log reduction of
MS2. In bacteria antiviral efficacy, carvacrol nanoemulsions (1.0% v/v) dissolved in
nuclease-free distilled water leading to 0.35 log reductions of Escherichia coli after 15 min
contact time. However, when contact time was increased to 30 and 60min, the treatment
showed no log reduction of Escherichia coli.
3.2. Introduction
HuNoV is a major leading cause of foodborne illness, and now this pathogen is recognized
as a leading cause of diarrhea for all ages of person. (Patel et al., 2009). NoVs are
nonenveloped single-stranded RNA virus. The viral capsid typically is 27- 35 nm in
diameter, and has a 7.5-7.7-kilobase in length of positive-sense genome that consists of
three open reading frames (ORFs) (Glass et al., 2000; Jiang et al., 1993; Lambden et al.,
1993). ORF1 codes for a non-structural polyprotein, ORF2 and ORF3 codes major (VP1)
and minor (VP2) capsid proteins, respectively (Glasset et al., 2000; Prasad et al., 1999). The
viruses have an icosahedral capsid that contain of 180 copies of the VP1 that self-assemble
based on hydrophobic contacts, and the pI of VP1 makes it negatively charged in neutral
pH (Smithet et al., 2019). One of the major challenges is their general resistance to many
commonly used inactivation agents (Hirneisen et al., 2010) and the lack of natural
disinfectants can efficiently inactive for norovirus capsid (Kamarasu et al., 2018). Therefore,
we applied novel spontaneous Nano-emulsification method to form a carvacrol
nanoemulsion against bacteriophage MS2 and E. coli.

The carvacrol with higher antibacterial properties contains a high percentage of phenolic
compounds, causing irreversible damage to the bacterial membrane proteins and membrane
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(Donsì et al., 2014). However, essential oils and their active components have only
displayed moderate inactivation of noroviruses surrogate (<1-3 log10 reduction on MNV),
therefore no food-grade, natural inactivation agents currently used in foods or on food
contact surfaces (Gilling et al., 2014).

Since the water solubility of carvacrol is as low as 0.11-0.83 g/l at room temperature (Chen
et al., 2014), it is difficult to directly inactivate MS2 by only using carvacrol in a disinfectant
solution. Although NoV do not have a lipid membrane, we hypothesize the positively
charged nanoemulsions will still better deliver carvacrol to the negatively charged viral
capsid that has hydrophobic contacts that hold the capsid together.

Nanoemulsions can enhance delivery of the active component against environmental
stresses and increase the partition of the hydrophobic component to aqueous phase (Chang
et al., 2013). The antimicrobial activity of carvacrol was found to be dependent on the
composition of nanoemulsion (type of surfactant, concentration of oil phase, aqueous phase
and ratio between carvacrol and MCT). The desired nanoemulsion droplet size and the
solubility properties are defined to formulate a nanoemulsion. Additionally, the study
(McClements et al., 2011) proved a small particle size of nanoemulsion (100nm-1000nm)
that can improve physical stability and increased bioactivity of lipophilic active ingredients

Many essential oils have lower water solubility, which can lead to rapid nanoemulsion
destabilization through a phenomenon known as Ostwald ripening, i.e., diffusion of the oil
from small droplets to large droplets. Eventually, this leads to oil and aqueous phase
separation, therefore the nanoemulsion may become unstable. Addition of highly lipophilic
triglycerides (such as MCT) can prevents Ostwald ripening and stabilizes essential oil
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nanoemulsions (Ziani et al., 2011).

Carvacrol oil-in-water nanoemulsions can stabilized by a nonionic surfactant (Tween 80),
Tween 80 dissolved in sterile deionized distilled water will be prepared to determine the
optimum interfacial composition to obtain the stable and smaller droplets with high
antimicrobial efficacy. Addition of a cationic surfactant to nanoemulsions further enhances
antimicrobial activity (Ziani et al., 2011). The mechanism of antibacterial action of essential
oil is mainly based on the hydrophobicity of their constituent molecules. Indeed, the
essential oil with higher antibacterial properties contain a high percentage of phenolic
compounds, capable of interacting with the cytoplasmic membrane, causing its irreversible
damage (Donsì et al., 2014).

Previous work for bacteria and fungi have demonstrated that restructuring essential oils into
positively charged nanoemulsions can enhance antimicrobial efficacy by 1-2 log (SalviaTrujillo et al. 2014). In this study, we hypothesize that incorporation of a strongly oxidizing
essential oil (carvacrol) into a nanoemulsion with cationic surfactant (CTAB) will enhance
delivery of a nanoemulsion to negatively charged norovirus particles. The 0.5 and 1.0% (v/v)
concentration of carvacrol nanoemulsions were exam as a model microorganism of desired
droplet size and charge.

The hypothesis of development of an efficacious carvacrol nanoemulsion (>4 log10
reduction of viral titer) that can be incorporated into foods or used on food contact surfaces
is of significant interest to the food industry as well as for public health.
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3.3. Materials and Methods
3.3.1. Bacterial Hosts and Cell Lines
Bacteriophage MS2 was kindly provided as a gift by L-A. Jaykus (North Carolina
State University, Raleigh, NC) and its host Escherichia coli strain (ATCC 15597),
were purchased from ATCC (Manassas, VA).
3.3.2. Escherichia Coli Preparation
Incubated Escherichia coli was kept at -80°C in a mixture of TSB containing 0.1%
thiamine and 0.2% glucose and 50%v/v of glycerol as frozen stock. Before use,
Escherichia coli was streaked in appropriate selective media (5ml TSB containing 0.1%
thiamine and 0.2% glucose) with cultured tubes at 37°C in an atmosphere containing
5% CO2 for 18 h.
3.3.3. Bacteriophage MS2 Plaque Assay
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1%
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at
37 °C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds
to approximately 2.6 × 108 CFU/ml for cultures of Escherichia coli strains. Warmed
1.0% TSA plates containing 0.1% thiamine and 0.2% glucose in 37°C for at least 1
hour prior to plaque assay beginning. Melted and tempered desired tubes of 9ml-0.5%
TSA containing 0.1%thiamine and 0.2% glucose in a 50°C water bath. MS2 stock (3.18
× 1011 PFU/ml) was serially diluted in TSB containing 0.1% thiamine and 0.2% glucose,
and 0.7 mL of diluted phage was mixed with 0.3 ml of 2-h Escherichia coli host. The
1-ml host-MS2 combination was then added to 9ml of 0.5% TSA containing 0.1%
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thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured on 1% TSA
containing 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C
overnight. To obtain accurate quantitative analyses of plaque numbers, petri plates
should have relatively diluted MS2 samples (25 to 250 PFU/plate).
3.3.4. Propagation of Bacteriophage MS2
Selected plate with complete lysis and flooded with 3ml TSB 0.1% thiamine and 0.2%
glucose. Gently scraped off the top layer of MS2 plaques formation surface into sterile
50ml tubes as over layer of complete lysis plaques suspensions. Bring volume to 40ml
with TSB containing 0.1% thiamine and 0.2% glucose. Adding 0.2g of EDTA and
0.026g of lysozyme to each tube and vortex for 10s. Incubated each tube at 37°C in an
atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h. The over
layer of complete lysis plaques suspensions were then centrifuged at 9280G for 10min.
Adding supernatant in 0.22um sterilize filter and then aliquoted to 1ml storage
cryogenic tubes. Storing at either 4°C for several weeks or -80°C for several years.
Cryoprotectant (such as glycerol) is not necessary.
3.3.5. Antiviral Effects of Nanoemulsion on MS2
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1%
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at
37°C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds
to approximately 2.6 × 108CFU/ml for cultures of Escherichia coli strains. Gently
thawed MS2 stock (8.71 × 1010PFU/ml) on ice, diluted in 1/100 (10ul MS2 in 990ul
nuclease-free distilled water). Each concentration of sterile-dilute Nano-emulsion
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(500ul) was mixed with an equal volume of MS2 (500ul) and incubated with gentle
rotation for desired time (10-60 min) at room temperature. Sterile-dilute nano-emulsion
was replaced with nuclease-free distilled water which also incubate with gentle rotation
for desired time (10 to 60min) at room temperature used as the untreated controls. After
incubation, treated MS2 and untreated control were neutralized in TSB containing 3%
meat extract. MS2 plaque assays were performed using incubated 2-h Escherichia coli.
MS2 treated with sterile-dilute nano-emulsion or water after neutralization with TSB
containing 3% meat extract was serially diluted in TSB containing 0.1% thiamine and
0.2% glucose, and 0.7 ml of diluted phage was mixed with 0.3 ml of 2-h Escherichia
coli host. The 1-ml host-MS2 combination was then added to 9ml of 0.5% TSA
containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured
on 1% TSA 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C
overnight before counting.
3.3.6. Antibacterial Effects of Nanoemulsion on Escherichia coli
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine
and 0.2% glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul
of overnight Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1%
thiamine and 0.2% glucose in a 100ml conical flask. Incubate the Escherichia coli at
37 °C in an atmosphere containing 5% CO2 using an incubator shaker (100 rpm) for 2h
until the optical density at 600 nm of 0.60. As a guideline, an OD600 of 0.6 corresponds
to approximately 2.6 × 108 CFU/ml for cultures of Escherichia coli strains. A 0.5mlaliquot of incubated bacterial culture was mixed with 0.5ml of the carvacrol
nanoemulsion and 9.0 ml of nuclease-free distilled water. To determine the inactivation
kinetics, an aliquot was taken after 15, 30 and 60min of contact time. A control was
performed with the same method, replacing the nanoemulsion by nuclease-free distilled
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water. Minimum inhibitory concentration (MIC) were performed by using Escherichia
coli treated with sterile-dilute nano-emulsion or water. Serially diluted treated and
untreated Escherichia coli in TSB containing 0.1% thiamine and 0.2% glucose, and 0.1
ml of diluted cultures were poured on 1% TSA 0.1% thiamine and 0.2% glucose bottom
agar plates. And incubated at 37°C overnight before counting.
3.3.7. Statistical analysis
Each experiment was performed in triplicate and all values are reported as the mean ±
standard deviation (SD) by Microsoft Excel. Results from the plaque assay of
treatments and non-treatment controls were statistically assayed in duplicate plates and
two replicate analyses were made of each nano-emulsion sample.
3.4. Results
The degree to which restructuring carvacrol into positively charged nanoemulsions was
investigated in this work. The levels of 0.5% and 1.0% carvacrol were chosen for a number
of reasons. Based on work presented in Chapter 2, 0.5 to 1.0% carvacrol produced stable
nanoemulsions with the desired droplet size (from 112.3to 95.5 nm) and Zeta-potential
(from+13 to +11 mV). Additionally, previous work (Gilling et al., 2014) demonstrated
these concentrations exhibited antiviral activity (nearing 4 log reduction after 24h) on MNV
using 0.5% purified carvacrol. Therefore, 0.5 to 1.0% of carvacrol nanoemulsions were
made in this study.
3.4.1. Effect of 0.5 and 0.83% Carvacrol Nanoemulsions Dissolved in PBS on MS2
The 0.5 and 0.83% carvacrol nanoemulsions dissolved in PBS had no antiviral effect
(Fig. 3). 2.5×107 and 2.7×107 viral titers of MS2 were observed across treatment groups
(MS2 was treated with 0.5 and 0.83% carvacrol nanoemulsion) compared with
untreated control (2.1×107) and neutralization control (2.1×105) by same treatment
contact time (60min). Although treatment with PBS in different plaques population in
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MS2, it was not significantly different from nuclease-free distilled water or PBS.
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Fig. 3. Effect of 0.5 and 0.83% carvacrol nanoemulsions dissolved in PBS on MS2. At 60
min contact time, 0.5 and 0.83% carvacrol nanoemulsion dissolved in PBS shows no
antiviral efficacy compared with non-treatment control.

3.4.2. Effect of 0.5 and 1.0% Carvacrol Nanoemulsions Dissolved in Nuclease-Free
Distilled Water on MS2
The results of antiviral effect are shown in Fig. 4. The antiviral efficacy of MS2 was
determined by comparison with the plaque reductions at the same treatment contact
time (60min) at room temperature. 8.8×106 and 1.4×106 viral titers of MS2 were
observed when MS2 treated with 0.5% and 1.0% carvacrol nanoemulsions 7.1×106 viral
titers were observed at untreated control. The antiviral effect of 0.5% carvacrol
nanoemulsion showed no antiviral activity than non-treatment control. However,
carvacrol was examined at concentrations of 1.0%, 0.7 log reductions in comparison
with the non-treatment controls at 60min contact time. In order to validate the
experimental treatment protocol, 1.0% bleach showed complete inactivation, as

49

previously reported (Whitehead et al., 2010). Therefore, 0.5 and 1.0% carvacrol

MS2 titer (PFU/ml)

nanoemulsions dissolved in water showed lower efficacy on MS2 than carvacrol alone.
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Fig. 4. Effect of 0.5 and 1.0% carvacrol nanoemulsions dissolved in nuclease-free distilled
water on MS2. 0.5 and 1.0% carvacrol nanoemulsions dissolved in nuclease-free distilled
water showed lower antiviral efficacy. The antiviral effect of 0.5% carvacrol
nanoemulsion showed no antiviral activity than non-treatment control. However,
carvacrol was examined at concentrations of 1.0%, a 0.7 log10 reductions in comparison
with the non-treatment controls at 60 min contact time.

3.4.3. Effect of 1.0% Carvacrol Nanoemulsion Dissolved in Nuclease-Free Distilled
Water on Escherichia Coli in Different Contact Time
In order to see if carvacrol nanoemulsions required a lipid membrane for efficacy, the
antimicrobial effects of a 1.0% carvacrol nanoemulsion optimized against Escherichia
coli showed in Fig. 5. The treatment on 1.0% carvacrol nanoemulsion dissolved
nuclease-free distilled water shows low antibacterial efficacy. 2×107 CFU/ml bacterial
titers were observed at non-treatment control and 9×106, 2×107 and 1.6×107 CFU/ml
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were observed after contacted with 1% carvacrol nanoemulsion at 15, 30 and 60min.
The results indicated that the 1.0% carvacrol nanoemulsions at 15, 30 and 60 min
contact time achieved 0.35, -0.04 and 0.03 log10 bacteria colony reduction compare
with non-treatment control. In order to present the experiment protocol, 1.0% bleach in
30 min contact time exams completely inactive antibacterial effect. In addition, no
significant difference was observed between MS2 bacterial phage and Escherichia coli
microorganism reduction on 1.0% nanoemulsion dissolved in nuclease-free distilled
water,
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Fig. 5. Effect of 1.0% carvacrol nanoemulsion dissolved in water on Escherichia Coli. In
different contact time. 1.0% carvacrol nanoemulsion dissolved in nuclease-free distilled in
water shows low antibacterial efficacy. At 15, 30 and 60 min contact time, 1.0% carvacrol
nanoemulsion achieved 0.35, -0.04 and 0.03 log10 bacteria colony reduction compare with
non-treatment control.

3.4.4. Effect of 1.0 and 10% Carvacrol Emulsion Dissolved in Water on Escherichia
Coli in 60min Contact Time
The antimicrobial effects of 1.0% carvacrol optimized against Escherichia coli showed
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in Fig. 6. The results indicated that the 1.0% carvacrol at 60 min contact time has no
bacteria colony reduction. 1.9 ×107 CFU/ml was observed after contacted with 1%
carvacrol compare with non-treatment control (1.7×107 CFU/ml). Additionally, the both
results of 1% carvacrol nanoemulsion and 1% carvacrol showed the similar effect (no
antibacterial reduction) on Escherichia coli at 60 min contact time. However, in 10%
carvacrol treatment at same contact time, a 7.2 log10 reduction was achieved. Therefore,
the higher concentration (10%) of carvacrol itself has higher antibacterial effect than

Bacterial titers (CFU/ml)
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Fig. 6. Effect of 1.0 and 10% carvacrol emulsion dissolved in water on Escherichia Coli. In
60min contact time. 1.0% carvacrol essential oil dissolved in nuclease-free distilled water
shows no antibacterial efficacy compared to non-treatment control However, 7.2 log10
reductions were observed at 10% carvacrol in comparison with the non-treatment controls at
60 min contact time.
3.5. Discussion
In this work, restructuring carvacrol in positively charged nanoemulsions did not enhance
antiviral efficacy against bacteriophage MS2. The hypothesis that positively charged
nanoemulsions would enhance delivery of carvacrol to the hydrophobic contacts that hold
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the negatively charged viral protein capsid together was found not true. This suggests that
nanoemulsions made using the low energy method may require the target microorganism
to have a lipid membrane to enhance antimicrobial efficacy.

Therefore, in this study, we applied different concentrations of carvacrol nanoemulsions
dissolved in different aqueous phase (nuclease-free distilled water) to exam antimicrobial
efficacy on MS2 and Escherichia coli. In different concentration (0.5 and 1.0%) of
carvacrol nanoemulsion dissolved in nuclease-free distilled water showed -0.09 and 0.7
log10 antiviral reduction; these two concentrations of nanoemulsion did not show
significant reduction compared to the non-treatment control.

Various mechanisms, such as applied low concentration (0.5%) of carvacrol could decrease
the antiviral efficacy. The results showed that 1% carvacrol nanoemulsion dissolved in
water which has higher viral reduction (0.7 log10 reduction) than 0.5% nanoemulsion (-0.09
log reduction). Therefore, we could increase the higher ratio of carvacrol that may increase
the antiviral efficacy. For example, we can raise carvacrol from 0.5 or 1.0% to 5% that may
increase antiviral efficacy, and could be grounds for future work.

However, a previous study (Terjung et al., 2012) proved that essential oils prefer to stay at
oil-in-water interfaces, therefore, the reduction of the specific interfacial area of emulsions
by increasing the essential oil droplet size caused the increase of essential oil concentration
in aqueous phase. When the concentration of carvacrol nanoemulsion is increased, the
nanoemulsion droplet size may also increase—destabilizing the nanoemulsion. In addition,
when raising carvacrol from 0.5 or 1.0% to 10%, we may reduce the concentration of
surfactant (Tween 80) that may increase carvacrol nanoemulsion droplet.
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To optimize carvacrol nanoemulsion droplet size, adding an appropriate ratio between oil
and surfactant phase can helps formation of small droplets. In the field of nutraceutical
delivery systems, nanoemulsion of appropriate droplet size is between 10 nm and 200 nm
(Solans et al., 2005; Sagalowicz et al., 2010) because they can enhance the cell absorption
by enabling passive mechanisms by pass through the cellular membrane due to their subcellular size (Donsì et al., 2012). Moreover, increasing the surfactant concentration help
formulate the smaller droplets size because surfactant can lowers the interfacial tension at
the oil-in-water interface (Chuesiang et al., 2019). Therefore, design criteria for the choice
of the higher concentration in the formulation of the carvacrol nanoemulsion-based delivery
system should be took into account on targeting bacteriophage MS2.

Since significant antimicrobial properties have been reported for carvacrol it has potential
to be used as an antimicrobial agent in the food industry (Mazarei et al., 2019). In this study,
antibacterial effects of 1.0% carvacrol nanoemulsion showed slight effect (0.35 log10
reduction) against Escherichia coli at 15 min contact time while, 1% carvacrol
nanoemulsion showed no antibacterial effect at 30 and 60 min contact time on Escherichia
coli.

As previous described in section 3, various mechanisms, such as applied low concentration
of carvacrol, could decrease the antibacterial efficacy. The higher ratio of carvacrol
essential oil may increase antibacterial efficacy. For example, raising carvacrol from 1.0%
to 10% may increase antiviral efficacy. However, increasing the concentration of carvacrol
nanoemulsion, can increase droplet size on nanoemulsion. The antimicrobial activity
against Escherichia coli resulted to be significantly dependent on emulsion droplet size,
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and not to be affected by emulsion formulation, in agreement with the behavior observed
for the plant-base emulsions, in particular with nanoemulsions of sub-cellular mean droplet
size (<200 nm) caused a higher inactivation (Donsì et al., 2012). Therefore, these results
demonstrate that the 1% carvacrol nanoemulsion has low antibacterial efficacy in 15, 30
and 60 min contact time.

3.6. Conclusion
In conclusion, in this study, we applied different concentration of carvacrol nanoemulsion to
evaluate whether the desire of droplet size and charged can enhance delivery to negatively
charged viral capsid. The results showed low antimicrobial activities regardless of all
concentration. However, 10% carvacrol showed strong antibacterial affect (7 log10 reduction),
the results proved that carvacrol is an antimicrobial agent as reports from recent studies. In
future work, we can raise carvacrol nanoemulsion concentration to 5%, that may increase
antimicrobial compound for interacting with microorganism.
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CHAPTER 4
CARVACROL EMULSION ANTIMICROBIC EFFICACY ON BACTERIOPHAGE
MS2 AND ESCHERICHIA ECOLI

4.1. Abstract
Carvacrol is considered to improve food safety and the health of customers, and have been
registered by U.S. Food and Drug Administration and recognized as safe component. Carvacrol
is the antimicrobial monoterpene phenolic compounds which contains with lipophilic and
volatile secondary metabolites that can thus interact with the cell physicochemical properties.
In this study, the antimicrobial efficacy of carvacrol oil-in-water emulsions of concentrations
of 0.1, 0.5, 1.0, and 10% were examined on bacteriophage MS2; 1.0 and 10% carvacrol were
also examined on Escherichia coli. In addition, carvacrol oil-in-water emulsion stabilized by a
nonionic surfactant (Tween 80) and cationic surfactant (CTAB) or in combination with anionic
surfactant (sodium dodecyl sulfate) in inactivation of MS2 was also investigated. In antiviral
efficacy, carvacrol at 0.1, 0.5, 1.0 and 10% have no reduction on bacteriophage MS2 at 60min
contact time. In antibacterial efficacy, the 1.0% concentration showed no bacteria colony
reduction on E. coli while 10% carvacrol showed 7.2 log10 reduction at 60min contact time. At
ionic surfactant on antiviral efficacy test, 0.1% sodium dodecyl sulfate (SDS) showed no
reduction while 0.2% CTAB and 0.25% SDS showed slight antiviral reduction (0.6 and 0.55
log reduction) on the phage. Moreover, a 2.5 log10 reduction was observed at 0.5% SDS on
MS2. Due to there is no antiviral reduction when we applied carvacrol along on MS2, thus we
added an appropriate amount of cationic or anionic surfactant to investigate whether additional
ionic surfactant can improve antiviral efficacy. In combination 1% carvacrol with surfactant
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study, incubated aliquot MS2 and cationic carvacrol emulsion contained (1% carvacrol plus
0.5% Tween 80 and 0.2% CTAB) at 60min, a 2 log10 reductions was observed on MS2. In
anionic emulsion (contained 1% carvacrol plus 0.25 or 0.5% SDS), mixed separately 0.25 or
0.5% SDS with MS2 for 30 min and 60 min. At both 0.25 and 0.5% SDS, the ~4.6 log10
reduction were observed at two different contact time (30 and 60min). In this study, both
cationic and anionic carvacrol emulsion can improve the antiviral efficacy, the results represent
a step forward in improving food safety and reduce viral plaques colony by using carvacrol oilin-water emulsion combining surfactant.
4.2. Introduction
Carvacrol, a monoterpene phenol, has emerged as a natural antimicrobial due to its wide
spectrum activity against food spoilage and pathogenic fungi, yeast and bacteria (Nostro et al.,
2012). Carvacrol is the primary component of oregano essential oil and has been identified as
a natural economical food preservative (Lu et al., 2010; Obaidat et al., 2009). It has recently
been reported that carvacrol could effectively reduce the infectivity of murine norovirus (MNV)
(Gilling et al., 2014), a HuNoVs surrogate, and rotavirus (Pilau et al.,2011). The area of
particular interest is their potential to inhibit some of the most serious foodborne pathogens,
such as Escherichia coli (Božik et al. 2018) . However, the effectiveness of carvacrol oil-inwater emulsion plus ionic surfactant against bacteriophage MS2 and Escherichia coli, as well
as its efficacy in food applications has yet to be explored.

Since the water solubility of carvacrol is as low as 0.11-0.83 g/l at 25°C (Chen et al., 2014), it
is difficult to directly inactive MS2 by only using carvacrol. Therefore, we applied surfactant
that provide information about the solute-solvent interactions. The surface-active properties
describe the interaction of surfactant molecules between two phases, a desired amount of
surfactant can adsorb with their molecular arrangement and reduce surface tension (Danov et
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al., 2012), that improve the carvacrol solubility in solution.

In oil-in-water emulsion system, the solubility of essential oil can be altered by using non-ionic
surfactants (Tween 80). The polysorbate family of surfactants (included Tween 80), can be used
by mixing water, the surfactant, and essential oil using a vortex mixer (Chen et al., 2014).
Additionally, a study (Kumar et al., 2018) suggested that non-ionic surfactant also help forms
a stable oil-in-water emulsion. Therefore, adding an appropriate amount of Tween80 for
suitability in carvacrol emulsion system could be took in account in this study.

Addition of a cationic surfactant to emulsions has been shown to further enhance antimicrobial
activity (Ziani et al., 2011). The mechanism of antibacterial effect of essential oil is mainly
based on the hydrophobicity of their constituent molecules. In the case of virus, the positively
charged compounds can adsorb on viral capsid by also electrostatic interaction which inhibit
viral adsorption on host cells. However, the microbial activities of cationic compounds have
mainly been focused on pathogenic bacterial but they were less studied on viruses (Pan et al.,
2006).

SDS, as a surfactant compound (Singer et al.,1993), makes the liquid spread more easily and
can lower the interfacial tension between two liquid (Li et al., 2013), which facilitates the
organic compound to penetrate the cell membrane and accumulate. Previous research
suggested SDS is able to cause significant damages to viral structures of both enveloped and
nonenveloped viruses; the result on combinations of SDS with chlorinated water improved
inactivation of HuNoV surrogates on fresh vegetables and Fruits (Predmore et al., 2011).
Another study (Zhou et al., 2017) also presents that the treatment of washing with levulinic
acid plus SDS was able to reduce MNV-1 and MS2 on strawberry (Aydin et al., 2013).
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In this study, we hypothesize that incorporation of nonionic (Tween 80) plus cationic (CTAB),
or anionic (SDS) surfactant will enhance the efficacy of a strongly oxidizing essential oil active
compound (carvacrol) on bacteriophage MS2 and Escherichia coli. The development of an
efficacious natural disinfectant (>4 log10 reduction of viral titer) that can be incorporated into
foods or used on food contact surfaces is of significant interest to the food industry as well as
for public health.
4.3. Materials and Methods
4.3.1. Bacterial Hosts, and Cell Lines
Bacteriophage MS2 was kindly provided as a gift by L-A. Jaykus (North Carolina State
University, Raleigh, NC) and its host Escherichia coli strain (ATCC 15597), were purchased
from ATCC (Manassas, VA).
4.3.2. Escherichia Coli Preparation
Incubated Escherichia coli was kept at -80°C in a mixture of TSB containing 0.1% thiamine
and 0.2% glucose and 50%v/v of glycerol as frozen stock. Before use, Escherichia coli was
streaked in appropriate selective media (5ml TSB containing 0.1% thiamine and 0.2% glucose)
with cultured tubes at 37°C in an atmosphere containing 5% CO2 for 18 h.
4.3.3. Bacteriophage MS2 Plaque Assay
Incubated Escherichia coli from frozen stock in 5mL TSB containing 0.1% thiamine and 0.2%
glucose at 37°C in an atmosphere containing 5% CO2 for 18h. Adding 300ul of overnight
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2%
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108 CFU/ml
for cultures of Escherichia coli strains. Warmed 1.0% TSA plates containing 0.1% thiamine
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and 0.2% glucose in 37 °C for at least 1 hour prior to plaque assay beginning. Melted and
tempered desired tubes of 9ml-0.5% TSA containing 0.1%thiamine and 0.2% glucose in a 50°C
water bath. MS2 stock (3.18 × 1011 PFU/ml) was serially diluted in TSB containing 0.1%
thiamine and 0.2% glucose, and 0.7 mL of diluted phage was mixed with 0.3 mL of 2-h
Escherichia coli host. The 1-ml host-MS2 combination was then added to 9mL of 0.5% TSA
containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and poured on 1%
TSA containing 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C
overnight. To obtain accurate quantitative analyses of plaque numbers, petri plates should have
relatively diluted MS2 samples (25 to 250 PFU/plate).
4.3.4. Propagation of Bacteriophage MS2
Selected plate with complete lysis and flooded with 3mL TSB 0.1% thiamine and 0.2%
glucose. Gently scraped off the top layer of MS2 plaques formation surface into sterile 50ml
tubes as over layer of complete lysis plaques suspensions. Bring volume to 40ml with TSB
containing 0.1% thiamine and 0.2% glucose. Adding 0.2g of EDTA and 0.026g of lysozyme
to each tube and vortex for 10s. Incubated each tube at 37°C in an atmosphere containing 5%
CO2 using an incubator shaker (100 rpm) for 2h. The over layer of complete lysis plaques
suspensions were then centrifuged at 9280G for 10 min. Adding supernatant in 0.22um sterilize
filter and then aliquoted to 1mL storage cryogenic tubes. Storing at either 4°C for several weeks
or -80°C for several years. Cryoprotectant (such as glycerol) is not necessary.
4.3.5. Carvacrol Emulsion Preparation.
Purified carvacrol (>98%) was purchased from Sigma-Aldrich (St. Louis, MO),
Polyoxyethylene-80 (Tween 80) and Hexadecyltrimethylammonium bromide (CTAB) was
purchased from (Markham, ON), were added with nuclease-free distilled water to form
emulsion’s aqueous phase. Sodium dodecyl sulfate (SDS) was purchased from Sigma-Aldrich
(St. Louis, MO), was added with nuclease-free distilled water to form emulsion’s aqueous
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phase. Initially, few different amounts of purified carvacrol were mix with nuclease-free
distilled water to form different concentration (0.1, 0.5, 1.0 and 10% v/v) of carvacrol
emulsion. Nuclease-free distilled water (Thermo Fisher, Waltham, MA) was added with 0.2%
of cationic surfactant (CTAB) and 0.5% Tween 80 for 1 min by using a vortex at room
temperature to form an aqueous phase. A 1.0% carvacrol was then added at aqueous phase then
all components were mixed for 1 min at 25 °C to make a cationic antimicrobial emulsion. In
combining different surfactant with purified carvacrol to form emulsion, a 0.1, 0.25 and 0.5%
(v/v) concentration of SDS were separately added with nuclease-free distilled water for 1 min
by using a vortex at room temperature to form an aqueous phase. A 1.0% (v/v) carvacrol was
then separately added to aqueous phase (with different concentration of SDS) then all
components were mixed for 1 min at 25 °C to make an antimicrobial emulsion.
4.3.6. Antiviral Effects of Carvacrol Emulsion on MS2.
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine and 0.2%
glucose at 37°C in an atmosphere containing 5% CO2 for 18 h. Adding 300ul of overnight
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2%
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108CFU/mL
for cultures of Escherichia coli strains. Gently thawed MS2 stock (8.71 × 1010 PFU/ml) on ice,
diluted in 1/100 (10ul MS2 in 990ul sterile nuclease-free distilled water). First, 500ul of 0.1,
0.5, 1.0 and 10% concentration of carvacrol emulsion were separately mixed with an equal
volume of MS2 (500ul) and incubated with gentle rotation for desired time (60 min) at room
temperature. In cationic antimicrobial, 500ul emulsion (contained 1.0% carvacrol, 0.2% CTAB
and 0.5% Tween 80) was mixed with an equal volume of MS2 (500ul) and incubated with
gentle rotation for desired time (60 min) at room temperature. Another emulsion was also tested
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on suspension assay, 500ul of 1.0% carvacrol emulsion contained with a different
concentration (0.1, 0.25 and 2.5% of SDS) was mixed with an equal volume of MS2 (500ul)
and incubated with gentle rotation for two different desired time (30 and 60min) at room
temperature. Antimicrobial carvacrol emulsion were replaced with sterile nuclease-free
distilled water which also incubate with gentle rotation for desired time (30 and 60 min) at
room temperature used as the untreated controls. After incubation, treated MS2 and untreated
control were neutralized in TSB containing 3% meat extract. MS2 plaque assays were
performed using incubated 2-h Escherichia coli. MS2 treated with 1.0% carvacrol emulsion or
water after neutralization with TSB containing 3% meat extract was serially diluted in TSB
containing 0.1%thiamine and 0.2% glucose, and 0.7 ml of diluted phage was mixed with 0.3
ml of 2-h Escherichia coli host. The 1-ml host-MS2 combination was then added to 9ml of
0.5% TSA containing 0.1% thiamine, 0.1% calcium chloride and 0.2% glucose, mixed and
poured on 1% TSA 0.1% thiamine and 0.2% glucose bottom agar plates, and incubated at 37°C
overnight before counting.
4.3.7. Antibacterial Effects of Carvacrol Emulsion on Escherichia Coli.
Incubated Escherichia coli from frozen stock in 5ml TSB containing 0.1% thiamine and 0.2%
glucose at 37°C in an atmosphere containing 5% CO2 for 18 h. Adding 300ul of overnight
Escherichia coli culture to inoculate at 29.7ml TSB containing 0.1% thiamine and 0.2%
glucose in a 100ml conical flask. Incubate the Escherichia coli at 37 °C in an atmosphere
containing 5% CO2 using an incubator shaker (100 rpm) for 2h until the optical density at 600
nm of 0.60. As a guideline, an OD600 of 0.6 corresponds to approximately 2.6 × 108CFU/mL
for cultures of Escherichia coli strains. A 500ul-aliquot of incubated bacterial culture was
mixed with 500ul of different concentration (1.0 and 10%) of carvacrol emulsion and 9.0 mL
of sterile nuclease-free distilled water. To determine the inactivation kinetics, an aliquot was
taken after 15, 30 and 60 min of contact time. A control was performed with the same method,
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replacing the carvacrol emulsion by sterile nuclease-free distilled water. Minimum inhibitory
concentration (MIC) were performed by using Escherichia coli treated with carvacrol emulsion
or water. Serially diluted treated and untreated Escherichia coli in TSB containing 0.1%
thiamine and 0.2% glucose, and 0.1 ml of diluted cultures were poured on 1% TSA 0.1%
thiamine and 0.2% glucose bottom agar plates. And incubated at 37°C overnight before
counting.
4.3.8. Statistical Analysis.
Each experiment was performed in triplicate and all values are reported as the mean ± standard
deviation (SD) by Microsoft Excel. Results from the plaque assay of treatments and nontreatment controls were statistically assayed in duplicate plates and two replicate analyses were
made of each nano-emulsion sample.
4.4. Results
4.4.1. Carvacrol and Its Surfactants Antiviral Effect on MS2
Low concentration (0.1, 0.5 and 1.0%) of carvacrol emulsion show low inactivation effect
(<0.05 log reduction) on MS2 (Fig. 7.); although treatment with increasing the concentration
on carvacrol to 10%, the results still showed no antiviral effect on the phage. At 0.2% CTAB
treatment, a slight reduction (0.6 log) on bacteriophage MS2 showed as viral titers in Although,
in 0.1% SDS showed no inactivation effect on bacteriophage MS2, a 0.55 and 2.5 log10
reduction were observed when treated with 0.25 and 0.5% SDS at same treatment contact time
showed as viral titers in Fig. 8.
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Fig. 7. Carvacrol antiviral effect on bacteriophage MS2. Effect of 0.1, 0.5,1.0 and 10%
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carvacrol against bacteriophage MS2 at 60 min treatment contact time.
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4.4.2. Cationic and Anionic Carvacrol Emulsion Antiviral Effect on MS2
The results of antiviral effect are shown in Fig. 9. The antiviral efficacy of bacteriophage MS2
was determined by comparison with the viral reductions at 60 min treatment contact time at
room temperature. 2.7×105 viral titers were observed at cationic carvacrol nanoemulsion
(contained 1% carvacrol 0.5% Tween 80 plus 0.2% CTAB) compared with non-treatment
control (1.5×107 viral titers). 2.3×101 and 1.9×101 viral titers of MS2 were observed when MS2
treated with anionic carvacrol emulsion (contained 1% carvacrol plus 0.25 or 0.5% SDS). The
antiviral effect of cationic carvacrol emulsion (contained 1% carvacrol, 0.2% CTAB and 0.5%
Tween 80) achieved 2 log10 reduction on MS2 compared to non-treatment control. When
applied anionic carvacrol emulsion (contained 1% carvacrol and either 0.25 or 0.5% SDS),

MS2 titer (PFU/ml)

both were achieved 5.3 log10 reductions on MS2.
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Fig. 9. Cationic and anionic carvacrol emulsion antiviral effect on MS2 at 60 min contact
time. Cationic carvacrol emulsion (contained 1% carvacrol, 0.2% CTAB and 0.5% Tween
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80) and anionic carvacrol emulsion (contained 1% carvacrol and 0.25% or 0.5% SDS)
antiviral effect on MS2.

4.4.3. Anionic Carvacrol Emulsion Antiviral Effect on MS2 at 30 min Contact Time
The results of antiviral effect are shown in Fig. 10.6×101 and 1×102 viral titers of MS2 were
observed when MS2 treated with anionic carvacrol emulsion (contained 1% carvacrol plus 0.25
and 0.5% SDS) and 4.6×106 viral titers were observed at untreated control. The antiviral
efficacy of MS2 was determined by comparison with the log10 reductions at the 30 min
treatment contact time at room temperature. In 30 min of treatment contact time, the antiviral
effect of anionic carvacrol emulsion contained different concentration (0.25 and 0.5%) of SDS.
A 4.8 log reduction was overserved in MS2 with 1% carvacrol emulsion (contained 0.25%SDS)
and a 4.6 log reduction was overserved in MS2 with 1% carvacrol emulsion (contained
0.5%SDS). Therefore, anionic carvacrol emulsion contains with different concentration of
SDS, all have strong antiviral efficacy on the phage at 30 min contact time showed in Fig. 10.

MS2 titer (PFU/ml)

6.0E+04
5.0E+04

4.6E+04

4.0E+04
3.0E+04
2.0E+04
1.0E+04
0.0E+00

Non-treatment
control
1

9.3E+00

1.4E+01

1% carvacrol
2
emulsion
(contained 0.25%
SDS)

1% carvacrol
3
emulsion
(contained 0.5%
SDS)

66

Fig. 10. Anionic carvacrol emulsion antiviral effect on MS2 at 30 min contact time.
Anionic carvacrol emulsion (contained 1% carvacrol, 0.25 or 0.5% SDS) antiviral effect
on MS2at 30 min contact time.

4.4.4. Effect Of 1.0 And 10% Carvacrol Emulsion Dissolving in Water on Escherichia
Coli in 60min Contact Time.
The antimicrobial effects of 1.0% carvacrol optimized against Escherichia coli showed in
Fig.6. The results indicated that the 1.0% carvacrol at 60 min contact time has no bacteria
colony reduction (1.9 ×107 CFU/ml bacterial titers compare with non-treatment control
1.7×107 CFU/ml). However, in 10% carvacrol treatment at same contact time, a 7.2 log10
reduction was achieved. Therefore, the higher concentration (10%) of carvacrol essential has
higher antibacterial effect than lower concentration (1%).
4.5. Discussion
We hypothesized carvacrol oil-in-water emulsion could improve antiviral efficacy, however
0.1, 0.5, 1.0 and 10% carvacrol emulsion dissolved in water shows no antiviral efficacy. There
is no viral reduction compare occurred following 0.1, 1.0 and 10% treated carvacrol than nontreatment control at 60 min treatment contact time. In addition, in antimicrobial efficacy, the
results indicated that 1.0% carvacrol emulsion at 60 min contact time has no bacteria colony
reduction. However, in 10% carvacrol emulsion treatment at same contact time (60 min), a 7.2
log reduction was achieved. It has been reported that hydrophobicity of carvacrol could be an
advantage for inducing antibacterial properties. It is well known that lipophilic compounds
possess a high affinity for cell membranes and their insertions induce changes in membrane
physicochemical properties. The interactions of antimicrobial compounds and cell membranes
are considered to affect both the lipid ordering and the bilayer stability, resulting in a membrane
integrity decrease and potential depolarization (Arfa et al., 2006). In addition, a study by (Ultee
et al., 1998) presented the carvacrol concentration increases, more of the compound is expected
to dissolve in the membrane and more damage of the membranes appears.
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Since the water solubility of carvacrol is low, we investigated the ability of three representative
surfactants (Tween 80) to enhance solubility to enhance carvacrol antimicrobial efficacy. The
solubility of essential oil can be altered by using a neutral surfactant Tween 80 (Chen et al.
2014) and addition of a cationic surfactant to emulsions can further enhances antimicrobial
activity (Ziani et al. 2011) due to the positive charge of CTAB. A 0.6 log reduction was
achieved when only apply 0.2% CTAB dissolved in nuclease-free distilled water, the results
showed the cationic surfactant has slight antiviral effect on bacteriophage MS2.

In 1% carvacrol emulsion (contained 0.5% Tween plus 0.2% CTAB), Tween 80 helps oil-inwater emulsion form smaller droplet size, the surfactant is favored by inequality in the
hydrocarbon chain length (Wang et al. 2009). The unequal surfactant chain length is expected
to lead to a more disarranged surfactant/oil interface, hence, producing a region of enhanced
oil mixing (Eastoe et al. 2003). In order to find an antiviral effect on bacteriophage MS2, the
positively charged compounds, including CTAB may enhance emulsions antiviral activity (LyChatain et al., 2013). Additionally, the positively charged compounds can adsorb on viral
capsid by also electrostatic interaction which inhibit viral adsorption on host cells (Pan et al.,
2006). At pH acid, phages have a neutral or positive charge leading to a reduction the
absorption of cationic compounds on phage. A lower cell viability have been observed when
the cell surface charge change from negative to positive (Ly-Chatain et al., 2013). In this study,
when we applied 0.2% CTAB surfactant along against bacteriophage MS2, a 0.6 log10
reduction was achieved. Therefore, we made a carvacrol emulsion (1.0% carvacrol plus 0.5%
Tween 80 and 0.2% CTAB), a 2 log10 reduction on MS2 was observed at 60 min contact time.
Although results showed a moderate antiviral efficacy, carvacrol emulsion (1.0% carvacrol
plus 0.5% Tween 80 and 0.2% CTAB) proved that the additional of CTAB cause further
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antiviral effect (compared with 1% carvacrol along) on MS2.

In addition, we also applied 1.0% carvacrol emulsion plus a different concentration (0.25 and
0.5%) of SDS to exam the antiviral efficacy on bacteriophage MS2. Anionic surfactants (SDS),
which can reduce the surface tension of water by adsorbing at the liquid-gas or liquid-liquid
interface and thus can potentially enhance the removal of viruses from fresh produce. Another
alternative is that the surfactants are able to directly denature the virus, resulting in inactivation
during sanitization (Predmore et al., 2011).

In the present study, we tested the different concentration (0.1, 0.25 and 0.5%) of SDS to exam
the anionic surfactant antiviral efficacy. Although 0.1% SDS showed no antiviral reduction,
0.5 and 2.5 log10 reduction were observed when applied 0.25 and 0.5% SDS on bacteriophage
MS2. Therefore, we tested 1% carvacrol emulsion in combination with 0.25 and 0.5%
concentration of SDS surfactants at two different contact times (30 and 60 min). In all cases,
two different concentration of SDS show significant antiviral efficacy at two different contact
time (30 and 60min). These results presented at 0.25 an 0.5% SDS concentration in treatment
with 30 and 60 min contact time, treated phage were all observed a >4.6 log viral reduction on
MS2. This is due to the fact that the viricidal activity of surfactants for sexually transmitted
mechanism in viral capsid (Howett et al., 1999); the capsid protein of norovirus surrogate
became aggregated after incubation with SDS and that the structure of viral capsid was severely
altered (Predmore et al., 2011).

4.6. Conclusion
Taken together, in anionic carvacrol nanoemulsions antiviral activities, the results suggest that
SDS as well as other surfactants can be useful in the inactivation of both enveloped and
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nonenveloped. Viruses. In future study, we can apply lower concentration of carvacrol to
combine with SDS. Since 1% carvacrol combine with 0.5% Tween 80 plus 0.2% CTAB or 1%
carvacrol combine with 0.2 or 0.5% SDS can show the strong antiviral efficacy. To lower down
the 1% carvacrol emulsion to 0.5% or 0.1% may still show the reduction on the phage.
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